ARS Pharmaceuticals (SPRY)

ARS Pharmaceuticals (SPRY) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• SPRY last traded at $3.05, -9.76% on the day.
• ARS Pharmaceuticals: P/E -1.4, revenue $116.93M over the last four quarters.
• Over the past year SPRY returned -65.96%; year to date -73.82%.

Updated 2026-11-03 13:26 UTC